Skip to main content

JANE STREET GROUP, LLC

Position in ATYR — aTYR PHARMA INC

CIK 1595888 NEW YORK, NY

Position in ATYR

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$37,830
-$109,490 QoQ
Shares Held
48,502
-74.2% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 109 holders
Holding Since
Sep 2021
12 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ATYR Over Time

Shares Held

Position Value (USD)

Derivatives in ATYR

reported options exposure · as of Mar 31, 2026
CallValue
$353,262
CallShares
452,900
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JANE STREET GROUP, LLC holds $1,247,243,084 across 314 Biotechnology names. ATYR ranks #278 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ATYR

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $353,262 452,900
2026-03-31 $37,830 48,502
2025-12-31 $35,000 44,700
2025-12-31 $227,461 290,500
2025-12-31 $147,320 188,149
2025-09-30 $8,796 12,200
2025-09-30 $493,019 683,800
2025-09-30 $164,232 227,785
2025-06-30 $184,664 36,423
2025-06-30 $513,084 101,200
2025-06-30 $92,274 18,200
2025-03-31 $527,009 174,507
2025-03-31 $243,110 80,500
2024-12-31 $720,401 199,006
2024-09-30 $41,807 23,754
2024-06-30 $44,391 28,456
2024-03-31 $121,172 62,140
2022-06-30 $28,744 10,157
2021-12-31 $102,339 13,700
2021-09-30 $1,554,496 171,200
2021-09-30 $1,243,060 136,901
2021-09-30 $470,344 51,800